Phase II trial of chemotherapy with temozolomide in combination with topotecan for central nervous system (CNS) metastases of solid tumors.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 21 Sep 2017
At a glance
- Drugs Temozolomide (Primary) ; Topotecan (Primary)
- Indications Cancer metastases; Solid tumours
- Focus Therapeutic Use
- 15 Sep 2017 Planned End Date changed from 1 Mar 2015 to 1 Nov 2014.
- 15 Sep 2017 Planned primary completion date changed from 1 Mar 2015 to 1 Nov 2014.
- 15 Sep 2017 Status changed from recruiting to withdrawn prior to enrolment.